University of Pittsburgh School of Medicine, Department of Psychiatry, Western Psychiatric Hospital, University of Pittsburgh Medical Center, United States of America.
Dalhousie University, Department of Psychiatry, Canada.
J Affect Disord. 2025 Jan 1;368:359-365. doi: 10.1016/j.jad.2024.09.107. Epub 2024 Sep 17.
Previous work indicates that polygenic risk scores (PRS) for bipolar disorder (BD) are elevated in adults and youth with BD, but whether BD-PRS can inform person-level diagnostic prediction is unknown. Here, we test whether BD-PRS improves performance of a previously published risk calculator (RC) for BD.
156 parents with BD-I/II and their offspring ages 6-18 were recruited and evaluated with standardized diagnostic assessments every two years for >12 years. DNA was extracted from saliva samples, genotyping performed, and BD-PRS calculated based on a 2021 meta-analysis. Using a bootstrapped and cross-validated penalized Cox regression, we assessed whether BD-PRS (alone and interacting with clinical variables) improved RC performance.
Of 227 offspring, 38 developed BD during follow-up. The penalized regression selected BD-PRS and interactions between BD-PRS and parental age at mood disorder onset (AAO), depression, and anxiety. The resulting RC discriminated offspring who developed BD (vs. those that did not) with good accuracy (AUC = 0.81); removing BD-PRS and its interaction terms was associated with a significant decrement to the AUC (decrement = 0.07, p = 0.039). Further exploration of selected interaction terms indicated that all were significant (p-values<0.02), indicating that BD-PRS has a larger effect on the outcome in offspring with depression and anxiety, whose affected parent had a younger AAO.
The addition of BD-PRS to clinical/demographic predictors in the RC significantly improved its accuracy. BD-PRS predicted BD on the person-level, particularly in offspring of parents with earlier AAO who already had symptoms of anxiety and depression at intake.
先前的研究表明,双相情感障碍(BD)的多基因风险评分(PRS)在 BD 成年患者和青少年患者中升高,但 BD-PRS 是否能为个体水平的诊断预测提供信息尚不清楚。在此,我们测试了 BD-PRS 是否能提高先前发表的 BD 风险计算器(RC)的性能。
招募了 156 名 BD-I/II 患者的父母及其 6-18 岁的子女,每两年对其进行一次标准化的诊断评估,持续了>12 年。从唾液样本中提取 DNA,进行基因分型,并基于 2021 年的荟萃分析计算 BD-PRS。使用 bootstrap 和交叉验证的惩罚 Cox 回归,我们评估了 BD-PRS(单独和与临床变量相互作用)是否改善了 RC 的性能。
在 227 名子女中,有 38 人在随访期间患上了 BD。惩罚回归选择了 BD-PRS 以及其与父母心境障碍发病年龄(AAO)、抑郁和焦虑的交互作用。由此产生的 RC 能很好地区分发生 BD(vs. 未发生 BD)的子女(AUC=0.81);去除 BD-PRS 及其交互项与 AUC 的显著降低相关(降低幅度=0.07,p=0.039)。对选定的交互项的进一步探索表明,所有交互项均有统计学意义(p 值<0.02),这表明在患有抑郁和焦虑且其受影响的父母 AAO 较早的子女中,BD-PRS 对结局的影响更大。
将 BD-PRS 添加到 RC 的临床/人口统计学预测因子中,显著提高了其准确性。BD-PRS 能在个体水平预测 BD,特别是在父母 AAO 较早且在入组时已经有焦虑和抑郁症状的子女中。